Is CF airway inflammation still relevant in the era of highly effective modulators?

J Cyst Fibros. 2022 Nov;21(6):901-903. doi: 10.1016/j.jcf.2022.08.013. Epub 2022 Aug 24.

Authors

Charles D Bengtson¹, Michael D Kim¹, Matthias Salathe²

Affiliations

¹ Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA.
² Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA. Electronic address: msalathe@kumc.edu.

PMID: 36028422
DOI: 10.1016/j.jcf.2022.08.013

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cystic Fibrosis Transmembrane Conductance Regulator
Cystic Fibrosis* / complications
Humans
Inflammation
Respiratory System

Substances

Cystic Fibrosis Transmembrane Conductance Regulator